The activity is largely administrative (tax withholding) and consistent with routine post-vesting equity practices. Traders should not interpret this as negative sentiment, especially given no open-market selling by the CEO or top executives beyond the director and accounting officer.
Price Chart
Executive Summary
A cluster of insider transactions at Jazz Pharmaceuticals over the past week includes one open-market sale by the Chief Accounting Officer and a director, while the CEO, legal chief, and accounting officer also surrendered shares for tax withholding. The total value of transactions is $3.4 million, but the majority are non-cash tax events, not economic selling.
Key Financial Metrics
Key Facts
- SVP & Chief Accounting Officer Patricia Carr sold $235,444 in shares on March 9 and surrendered $268,205 in shares for tax withholding on March 5.
- CEO Renée Gala surrendered $1.33 million in shares for tax withholding on March 5.
- EVP & Chief Legal Officer Neena Patil surrendered $943,450 in shares for tax withholding on March 5.
- Director Bruce Cozadd sold $587,843 in shares on March 3.
- Total cluster value: $3.4 million, but only $823,287 represents open-market selling; the rest are tax-related share surrenders with no economic impact.
Financial Impact
$823,287 in net open-market selling, representing 0.007% of market cap — minimal financial impact
Risk Factors
- Perception risk: Clustered transactions may be misinterpreted as broad insider selling despite being mostly non-cash.
- Governance scrutiny: Repeated tax withholding events could prompt questions about executive compensation structure.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (5 trades, 7d window) | cluster-JAZZ-1773090979169 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Press Release | $213.76 $211.97 | ▼ −0.84% | ▼ −1.36% | $210.99 (−1.30%) |
Oct 9, 2026 17d ago | 8-K | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 8, 2026 17d ago | 144 | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 6, 2026 19d ago | 144 | $231.19 $222.45 | ▼ −3.78% | ▼ −3.36% | $210.99 (−8.74%) |
Oct 1, 2026 24d ago | 144 | $235.67 $236.04 | ▲ +0.16% | ▼ −0.52% | $210.99 (−10.47%) |
Sep 15, 2026 5w ago | 8-K | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 14, 2026 5w ago | Insider Cluster | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 10, 2026 6w ago | Insider Cluster | $245.80 $245.87 | ▲ +0.03% | ▲ +0.47% | $210.99 (−14.16%) |
Sep 2, 2026 7w ago | Insider Cluster | $247.57 $246.81 | ▲ +0.30% | ▼ −0.08% | $210.99 (+14.78%) |
Aug 31, 2026 7w ago | 144 | $243.71 $245.57 | ▲ +0.76% | ▲ +0.32% | $210.99 (−13.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers